Year |
Citation |
Score |
2015 |
McNeer NA, Anandalingam K, Fields RJ, Caputo C, Kopic S, Gupta A, Quijano E, Polikoff L, Kong Y, Bahal R, Geibel JP, Glazer PM, Saltzman WM, Egan ME. Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium. Nature Communications. 6: 6952. PMID 25914116 DOI: 10.1038/Ncomms7952 |
0.687 |
|
2015 |
Fields RJ, Quijano E, McNeer NA, Caputo C, Bahal R, Anandalingam K, Egan ME, Glazer PM, Saltzman WM. Modified poly(lactic-co-glycolic acid) nanoparticles for enhanced cellular uptake and gene editing in the lung. Advanced Healthcare Materials. 4: 361-6. PMID 25156908 DOI: 10.1002/Adhm.201400355 |
0.668 |
|
2014 |
Bahal R, Quijano E, McNeer NA, Liu Y, Bhunia DC, Lopez-Giraldez F, Fields RJ, Saltzman WM, Ly DH, Glazer PM. Single-stranded γPNAs for in vivo site-specific genome editing via Watson-Crick recognition. Current Gene Therapy. 14: 331-42. PMID 25174576 DOI: 10.2174/1566523214666140825154158 |
0.666 |
|
2012 |
Fields RJ, Cheng CJ, Quijano E, Weller C, Kristofik N, Duong N, Hoimes C, Egan ME, Saltzman WM. Surface modified poly(β amino ester)-containing nanoparticles for plasmid DNA delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 164: 41-8. PMID 23041278 DOI: 10.1016/J.Jconrel.2012.09.020 |
0.666 |
|
2011 |
McNeer NA, Chin JY, Schleifman EB, Fields RJ, Glazer PM, Saltzman WM. Nanoparticles deliver triplex-forming PNAs for site-specific genomic recombination in CD34+ human hematopoietic progenitors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 172-80. PMID 20859257 DOI: 10.1038/Mt.2010.200 |
0.688 |
|
2010 |
Hoimes CJ, Murelli RP, Kelly WK, Zhang AX, Cheng CJ, Fields RJ, Spiegel DA, Saltzman WM. Effect of vorinostat (V)-loaded PLGA nanoparticles (NP) surface modified with a PSMA ligand on prostate cancer (PC) cells. Journal of Clinical Oncology. 28: e13629-e13629. DOI: 10.1200/Jco.2010.28.15_Suppl.E13629 |
0.528 |
|
Show low-probability matches. |